The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Polyakova O.A.

Russian Medical Academy of Continuing Professional Education

Ostroumova O.D.

Russian Medical Academy for Continuous Professional Education

Myths about acetylsalicylic acid

Authors:

Polyakova O.A., Ostroumova O.D.

More about the authors

Journal: Non Nocere. New Therapeutic Journal. 2023;(9): 58‑64

Read: 1444 times

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Polyakova OA, Ostroumova OD. Myths about acetylsalicylic acid. Non Nocere. New Therapeutic Journal. 2023;(9):58‑64. (In Russ.)

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

About problems with underprescribing of acetylsalicylic acid in clinical practice, selection of optimal doses and forms of the drug.

Authors:

Polyakova O.A.

Russian Medical Academy of Continuing Professional Education

Ostroumova O.D.

Russian Medical Academy for Continuous Professional Education

Close metadata

References:

  1. World Heart Report 2023: Confronting the World’s Number One Killer. Geneva, Switzerland. World Heart Federation. 2023. [Electronic resource]. Accessed: 16 September 2023. https://world-heart-federation.org/wp-content/uploads/World-Heart-Report-2023.pdf
  2. Gremmel T, Michelson AD, Frelinger AL III, et al. Novel aspects of antiplatelet therapy in cardiovascular disease. Res Pract Thromb Haemost. 2018;2(3):439-449. https://doi.org/10.1002/rth2.12115
  3. Patrono C. Fifty years with aspirin and platelets. Br J Pharmacol. 2023;180(1):25-43. https://doi.org/10.1111/bph.15966
  4. Ministry of Health of the Russian Federation. Clinical recommendations “Stable ischemic heart disease”. Year of approval: 2020. Date of access: October 04, 2023. https://cr.minzdrav.gov.ru/recomend/155_1
  5. Ministry of Health of the Russian Federation. Clinical recommendations “Acute myocardial infarction with ST-segment elevation electrocardiogram”. Year of approval: 2020. Date of access: October 04, 2023. https://cr.minzdrav.gov.ru/recomend/157_4
  6. Ministry of Health of the Russian Federation. Clinical Recommendations “Acute coronary syndrome without ST-segment elevation electrocardiogram”. Year of approval: 2020. Date of access: October 04, 2023. https://cr.minzdrav.gov.ru/recomend/154_3
  7. Ministry of Health of the Russian Federation. Clinical recommendations “Ischemic stroke and transient ischemic attack in adults”. Year of approval: 2021 Date of access: October 04, 2023. https://cr.minzdrav.gov.ru/recomend/171_2
  8. National guidelines for the diagnosis and treatment of lower extremity arterial disease (2019). Access date: October 04, 2023. https://www.angiolsurgery.org/library/recommendations/2019/recommendations_LLA_2019.pdf
  9. Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407-477. https://doi.org/10.1093/eurheartj/ehz425
  10. Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39(9):763-816. https://doi.org/10.1093/eurheartj/ehx095
  11. Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023; ehad191. https://doi.org/10.1093/eurheartj/ehad191
  12. Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227-3337. https://doi.org/10.1093/eurheartj/ehab484
  13. Orlova Y.A. Some issues of administering acetylsalicylic acid in clinical practice. “Arterial’naya Gipertenziya” (“Arterial Hypertension”). 2015;21(5):536-544. (In Russ.) https://doi.org/10.18705/1607-419X-2015-21-5-536-544
  14. Yoo SGK, Chung GS, Bahendeka SK, et al. Aspirin for Secondary Prevention of Cardiovascular Disease in 51 Low-, Middle-, and High-Income Countries. JAMA. 2023;330(8):715-724. https://doi.org/10.1001/jama.2023.12905
  15. Vora P, Soriano-Gabarró M, Russell B, et al. Long-Term Adherence and Persistence to Low-Dose Aspirin for the Prevention of Cardiovascular Disease: A Population-Based Cohort Study. Int J Clin Pract. 2022;2022:7786174. https://doi.org/10.1155/2022/7786174
  16. Sundström J, Hedberg J, Thuresson M, et al. Low-Dose Aspirin Discontinuation and Risk of Cardiovascular Events: A Swedish Nationwide, Population-Based Cohort Study. Circulation. 2017;136(13):1183-1192. https://doi.org/10.1161/CIRCULATIONAHA.117.028321
  17. Clerici B, Cattaneo M. Pharmacological Efficacy and Gastrointestinal Safety of Different Aspirin Formulations for Cardiovascular Prevention: A Narrative Review. J Cardiovasc Dev Dis. 2023;10(4):137. https://doi.org/10.3390/jcdd10040137
  18. Buryachkovskaya L.I., Lomakin N.V., Rusanova A.V. et al. Acetylsalicylic acid resistance: causes and effects. Russian Heart Journal. 2016;15(5):379-388. https://doi.org/10.18087/RHJ.2016.5.2261
  19. Angiolillo DJ, Prats J, Deliargyris EN, et al. Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation. Clin Pharmacokinet. 2022;61(4):465-479. https://doi.org/10.1007/s40262-021-01090-2
  20. Sagar KA, Smyth MR. A comparative bioavailability study of different aspirin formulations using on-line multidimensional chromatography. J Pharm Biomed Anal. 1999;21(2):383-392. https://doi.org/10.1016/s0731-7085(99)00177-6
  21. Bhatt DL, Grosser T, Dong JF, et al. Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus. J Am Coll Cardiol. 2017 Feb 14;69(6):603-612. https://doi.org/10.1016/j.jacc.2016.11.050
  22. Waller DG, Sampson AP. Medical pharmacology & therapeutics. Fifth Edition 2018. Elsevier Limited. P. 744. ISBN9780702071935.
  23. Lomakin N.V., Rusanova A.V., Buryachkovskaya L.I. et al. Comparison of antiaggregant efficacy of different forms of acetylsalicylic acid. Russian Heart Journal. 2014;78(4):206-215.
  24. Bhatt DL, Grosser T, Dong JF, et al. Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus. J Am Coll Cardiol. 2017;69(6):603-612. https://doi.org/10.1016/j.jacc.2016.11.050
  25. Barkagan Z.S., Kotovshchikova E.F. Comparative analysis of the main and side effects of different forms of acetylsalicylic acid. Clinical pharmacology and therapy. 2004;13(3):1-4.
  26. Grosser T, Fries S, Lawson JA, et al. Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin. Circulation. 2013;127(3):377-385. https://doi.org/10.1161/CIRCULATIONAHA.112.117283
  27. Cox D, Maree AO, Dooley M, et al. Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers. Stroke. 2006;37(8):2153-2158. https://doi.org/10.1161/01.STR.0000231683.43347.ec
  28. Haastrup PF, Grønlykke T, Jarbøl DE. Enteric coating can lead to reduced antiplatelet effect of low-dose acetylsalicylic acid. Basic Clin Pharmacol Toxicol. 2015;116(3):212-215. https://doi.org/10.1111/bcpt.12362
  29. Rocca B, Fox KAA, Ajjan RA, et al. Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis. Eur Heart J. 2018;39(19):1672-1686f. https://doi.org/10.1093/eurheartj/ehy066
  30. Kedir HM, Sisay EA, Abiye AA. Enteric-Coated Aspirin and the Risk of Gastrointestinal Side Effects: A Systematic Review. Int J Gen Med. 2021;14:4757-4763. https://doi.org/10.2147/IJGM.S326929
  31. Shiotani A, Haruma K, Nishi R, et al. Randomized, double-blind, pilot study of geranylgeranylacetone versus placebo in patients taking low-dose enteric-coated aspirin. Low-dose aspirin-induced small bowel damage. Scand J Gastroenterol. 2010;45(3):292-298. https://doi.org/10.3109/00365520903453182
  32. Huang ES, Strate LL, Ho WW, et al. A prospective study of aspirin use and the risk of gastrointestinal bleeding in men. PLoS One. 2010;5(12): e15721. https://doi.org/10.1371/journal.pone.0015721
  33. Huang ES, Strate LL, Ho WW, et al. Long-term use of aspirin and the risk of gastrointestinal bleeding. Am J Med. 2011;124(5):426-433. https://doi.org/10.1016/j.amjmed.2010.12.022
  34. Drapkina O.M., Kontsevaya A.V., Kalinina A.M., et al. 2022 Prevention of chronic non-communicable diseases in the Russian Federation. National guidelines. Cardiovascular Therapy and Prevention. 2022;21(4):3235. (In Russ.) https://doi.org/10.15829/1728-8800-2022-3235
  35. Steg PG, Huber K, Andreotti F, et al. Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J. 2011;32(15):1854-1864. https://doi.org/10.1093/eurheartj/ehr204
  36. Sidorov A.V. Antithrombotic effect of different acetylsalicylic acid drug formulations: is there a difference? Russian Journal of Cardiology. 2021;26(10):127-142. (In Russ.) https://doi.org/10.15829/1560-4071-2021-4734
  37. Lomakin N.V., Buryachkovskaya L.I., Zolin D.A., Kazey V.I. A Prospective, Initiative, Single-Center Open Post-Registration Comparative Study of Laboratory Efficacy of Various Forms of Acetylsalicylic Acid in a Cardioprotective Dose with Different Composition of Excipients: Results of the SFAIROS Study. Rational Pharmacotherapy in Cardiology. 2020;16(3):348-355. (In Russ.) https://doi.org/10.20996/1819-6446-2020-06-06
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.